The three distributors, accused of fueling the opioid crisis, are defendants in the federal opioid trial scheduled to begin Oct. 21 in Cleveland with two Ohio counties serving as bellwethers.
People familiar with the settlement talks told the WSJ the three distributors would pay $18 billion over 18 years if the plaintiffs’ lawyers agree to the deal.
Johnson & Johnson is also in talks to contribute additional money to the settlement deal and other drugmakers may join.
If the settlement is reached, it would be the first to achieve a broad resolution of opioid lawsuits outside of bankruptcy.
A bipartisan group of attorneys general in Texas, Tennessee, Pennsylvania and North Carolina have been leading the discussions for the settlement, according to the WSJ.
Any global resolution reached by distributors could affect or delay the trial.
Read the full article here.
More articles on opioids:
Judge backs Philadelphia’s supervised injection site
UPMC Chautauqua’s attempt to open methadone clinic scuttled
Purdue Pharma’s owners made larger profit than previously thought, court filing shows
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.